Acidic peptides enhanced genistein-dependent inhibition of human platelet aggregation: potential protective effect of digestible peptides plus genistein against atherosclerosis

Nutrition Research

Volumn 28, Issue 8, 2008, Pages 523-531

  Borgwardt, Kerstin ^a   Bonifatius, Susanne ^a   Gardemann, Andreas ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

ADP; Arachidonic acid; Atherosclerosis; Collagen; Epinephrine; Glycine max; Humans; Ischemic heart disease; Isoflavones; Soybeans; Thrombocytes

Indexed keywords

ADRENALIN; APYRASE; ARACHIDONIC ACID; ASPARAGINE; ASPARTIC ACID; COLLAGEN; GENISTEIN; GLUTAMIC ACID; GLYCININ; PEPTIDE; PROTEIN BETA CONGLYCININ; SOYBEAN PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; SOYBEAN; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADULT; ARACHIDONIC ACID; ATHEROSCLEROSIS; COLLAGEN; DIPEPTIDES; EPINEPHRINE; FEMALE; GENISTEIN; HUMANS; MALE; PEPTIDES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SOYBEAN PROTEINS;

GLYCINE MAX;

EID: 48949119136     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2008.03.017     Document Type: Article

References (47)

1. American Heart Association. 2001 Heart and stroke statistical update (2000), American Heart Association, Dallas, Texas
2. WHO Regional Office for Europe. The European Health Report 2002 (2002), WHO Regional Publications, Copenhagen European Series No. 97
3. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med 340 (1999) 115-126
4. Kullo I.J., Gau G.T., and Tajik A.J. Novel risk factors for atherosclerosis. Mayo Clin Proc 75 (2000) 369-380
5. Rajaram S. The effect of vegetarian diet, plant foods, and phytochemicals on hemostasis and thrombosis. Am J Clin Nutr 78 (2003) 552S-558S
6. Ruggeri Z.M. Platelets in atherothrombosis. Nat Med 8 (2002) 227-234
7. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8 (2002) 1211-1217
8. Gross P.L., and Aird W.C. The endothelium and thrombosis. Semin Thromb Hemost 26 (2000) 463-478
9. Potter S.M. Soy protein and cardiovascular disease: the impact of bioactive components in soy. Nutrition Reviews 56 (1998) 231-235
10. Anthony M.S., Clarkson T.B., and Williams J.K. Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am J Clin Nutr 68 (1998) 1390S-1393S
11. Vitolins M.Z., Anthony M.S., and Burke G.L. Soy protein isoflavones, lipids and arterial disease. Curr Opin Lipidol 12 (2001) 433-437
12. Kraus R.M., Deckelbaum R.J., Ernst N., Fischer E., Howard B.V., Knopp R.H., et al. Dietary guidelines for healthy American adults. Circulation 94 (1996) 1795-1800
13. Yu-Poth S., Zhao G., Etherton G., Naglak M., Jonnalagadda S., and Kris-Etherton P.M. Effects of the national cholesterol education program's step I and step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 89 (1999) 632-646
14. Food and Drug Administration. Food labelling, health claims, soy proteins, and coronary heart disease. Fed Regist 64 (1999) 57700-57733
15. Kondo K., Suzuki Y., Ikeda Y., and Umemura K. Genistein, an isoflavone included in soy, inhibits thrombotic vessel occlusion in the mouse femoral artery and in vitro platelet aggregation. Eur J Pharmacol 455 (2002) 53-57
16. Williams J.K., and Clarkson T.B. Dietary soy isoflavones inhibit in-vivo constrictor responses of coronary arteries to collagen-induced platelet activation. Coron Artery Dis 9 (1998) 759-764
17. Peluso M.R., Winters T.A., Shanahan M.F., and Banz W.J. A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. J Nutr 130 (2000) 2333-2342
18. Kottra G., Stamfort A., and Daniel H. PEPT1 as a paradigm for membrane carriers that mediate electrogenic bidirectional transport of anionic, cationic, and neutral substrates. J Biol Chem 277 (2002) 32683-32691
19. Daniel H., and Kottra G. The protein oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch-Eur J Physiol 447 (2004) 610-618
20. Adibi S.A. The oligopeptide transporter (Pept-1) in human intestine: biology and function. Gastroenterology 113 (1997) 332-340
21. Adibi S.A., and Mercer D.W. Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals. J Clin Invest 52 (1973) 1586-1594
22. Adibi S.A., and Soleimanpour M.R. Functional characterization of dipeptide transport system in human jejunum. J Clin Invest 53 (1974) 1368-1374
23. Adibi S.A., Morse E.L., Masilamani S.S., and Amin P.M. Evidence for two different modes of tripeptide disappearance in human intestine. Uptake by peptide carrier systems and hydrolysis by peptide hydrolases. J Clin Invest 56 (1975) 1355-1363
24. Budde U. Diagnose von Funktionsstörungen der Thrombozyten mit Hilfe der Aggregometrie. J Lab Med 26 (2002) 564-571
25. Gulati G.K., and Hyun B.H. The automated CBC. Hematol Oncol Clin North Am 8 (1994) 593-603
26. Möller G. Aggregationsprofiler PAP 4ff user manual, Issue 11/02; 2002.
27. Shattil S.J., Cunningham M., and Hoxie J.A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70 (1987) 307-312
28. Ramstrom S., Ranby M., and Lindahl T.L. Synergistic action between inhibition of 2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation. Thromb Haemost 89 (2003) 132-141
29. Ginsberg M.H., Frelinger A.L., Lam S.C.T., Forsyth J., McMillan R., Plow E.F., et al. Analysis of platelet aggregation disorders based on flow cytometric analysis of platelet membrane glycoprotein IIb-IIIa with conformation specific monoclonal antibodies. Blood 76 (1990) 2017-2023
30. McEver R.P. The clinical significance of platelet membrane glycoproteins. Hematol Oncol Clin North Am 4 (1990) 87-105
31. Michelson A.D., Barnard M.R., Krueger L.A., Frelinger A.L., and Furman M.I. Evaluation of platelet function by flow cytometry. Methods 21 (2000) 259-270
32. Krishnaiah P.R. Handbook of statistics: 1. Analysis of variance (1994), Elsevier Science BV, Amsterdam
33. Daniel W.W. Applied nonparametric statistics (1978), Houghton Mifflin Company, Boston
34. Verschuren W.M.M., Jacobs D.R., and Bloemberg B.P.M. Serum cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 274 (1995) 131-136
35. Anderson J.W., Johnstone M.B., and Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333 (1995) 276-282
36. Ozaki Y., Yatomi Y., Jinnhai Y., and Kume S. Effects of genistein, a tyrosine kinase inhibitor, on platelet functions. Biochem Pharmacol 46 (1993) 395-403
37. Rimbach G., Weinberg P.D., de Pascual-Teresa S., Alonso M.G., Ewins B.A., Turner R., et al. Sulfation of genistein alters its antioxidant property and its effect on platelet aggregation and monocyte and endothelial function. Biochim Biophys A 1670 (2004) 229-237
38. Singh M.P., Sinha S., Raghavan S.A.V., and Dikshit M. Inhibition of platelet aggregation by rat globin. Thromb Res 107 (2002) 201-207
39. Chavakis T., Boeckel N., Santoso S., Voss R., Isordia-Salas I., and Pixley R.A. Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogen. J Biol Chem 277 (2002) 23157-23164
40. Chiang T.M., and Kang A.H. A synthetic peptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation. J Clin Invest 100 (1997) 2079-2084
41. Qian Z.Y., Jolles P., Migliore-Samour D., and Fiat A.M. Isolation and characterization of sheep lactoferrin, an inhibitor of platelet aggregation and comparison with human lactoferrin. Biochim Biophys Acta 1243 (1995) 25-32
42. Qian Z.Y., Jolles P., Migliore-Samour D., Schoentgen F., and Fiat A.M. Sheep k-casein peptides inhibit platelet aggregation. Biochim Biophys Acta 1244 (1995) 411-417
43. Clare D.A., and Swaisgood H.E. Bioactive milk peptides: a prospectus. J Dairy Sci 83 (2000) 1187-1195
44. Veloso D. Thrombin-stimulated platelet aggregation is inhibited by kallikrein in a time- and concentration-dependent manner. Scand J Clin Lab Invest 63 (2003) 279-286
45. Setchell K.D.R., Brown N.M., Desai P.B., Zimmer-Nechimias L., Wolfe B., and Jakate A.S. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133 (2003) 1027-1035
46. Adlerkreutz H., Markkanen H., and Watanabe S. Plasma concentrations of phyto-estrogens in Japanese men. Lancet 342 (1993) 1209-1210
47. Shelnutt S.R., Cimino C.O., Wiggins P.A., Ronis M.J., and Badger T.M. Pharmacokinetics of the glucuronide and sulphate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am J Clin Nutr 76 (2002) 588-594